BHC:NYSE
Bausch Health Companies Inc
US$8.42
arrow_downward
-0.06%(-0.0050) 1D
ኖቬም 16, 4:00:04 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BHC...
Mkt. cap
3.15 ቢ
Avg. vol.
3.90 ሚ
Volume
329.00
52-wk high
US$9.04
52-wk low
US$4.33
EPS
-US$2.29
Beta
0.30
Shares outstanding
374.27 ሚ
No. of employees
20 ሺ
Mkt. cap
3.15 ቢ
Avg. vol.
3.90 ሚ
Volume
329.00
52-wk high
US$9.04
52-wk low
US$4.33
EPS
-US$2.29
Beta
0.30
Shares outstanding
374.27 ሚ
No. of employees
20 ሺ
News stories
From web sources and news partners
ChartMill
·
ከ30 ደቂቃዎች በፊት
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
FOREX.com
·
ከ56 ደቂቃዎች በፊት
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Investor's Business Daily
·
ከ1 ሰዓት በፊት
Analysts Expect 4 S&P 500 Stocks To Outgrow Nvidia Next Year
Profile
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20.3 ሺ
Founded1959
Headquartersላቫል, ኬበክ, ካናዳ
SectorHealth Care
IndustryPharmaceutical industry
Websitebauschhealth.com